ESR1 and neoplasm: For the BC subtypes that overexpress ER, molecular imaging using 16α-[18F]-fluoro-17β-estradiol ([18F]FES) has been recognized as a valuable tool to overcome clinical dilemmas, when distant metastasis cannot be safely reached for biopsies sampling or when ER heterogeneity is suspected between tumor lesions (39).